Introducing

Prof Tomas Kalincik

Hello, I’m Tomas, Head of the Clinical Outcomes Research (CORe) Unit.

TK - New Profile Pic

Prof Tomas Kalincik

Group Leader, Head of Neuroimmunology & MS at RMH

Send email
P: +61 3 9342 4404

a little bit about me

I am the Head of the CORe Unit at the University of Melbourne, as well as the Head of the Multiple Sclerosis and Neuroimmunology Service at The Royal Melbourne Hospital.

Together with the CORe team, I specialise in analytics of observational data in neurology. I am an active participant in the global MSBase collaboration, undertaking a role in the MSBase Scientific Leadership Group.

My research interests revolve around disease outcomes in Multiple Sclerosis and Neuromyelitis Optica. These comprise comparative treatment effectiveness, management of treatment failure, individual treatment response, personalised therapy, prognostics, epidemiology and utility of volumetric MRI.

Publications

Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
Tim Spelman, Serkan Ozakbas, Raed Alroughani, Murat Terzi, Suzanne Hodgkinson, Guy Laureys, Tomas Kalincik, Anneke Van Der Walt, Bassem Yamout, Jeannette Lechner-Scott, Aysun Soysal, Jens Kuhle, Jose Luis Sanchez-Menoyo, Yolanda Blanco Morgado, Daniele LA Spitaleri, Vincent van Pesch, Dana Horakova, Radek Ampapa, Francesco Patti, Richard Macdonell, Abdullah Al-Asmi, Oliver Gerlach, Jiwon Oh, Ayse Altintas, Namita Tundia, Schiffon L Wong, Helmut Butzkueven
Mult Scler. 2022 Nov 26:13524585221137502. doi: 10.1177/13524585221137502. Online ahead of print.

Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
Chao Zhu, Zhen Zhou, Izanne Roos, Daniel Merlo, Tomas Kalincik, Serkan Ozakbas, Olga Skibina, Jens Kuhle, Suzanne Hodgkinson, Cavit Boz, Raed Alroughani, Jeannette Lechner-Scott, Michael Barnett, Guillermo Izquierdo, Alexandre Prat, Dana Horakova, Eva Kubala Havrdova, Richard Macdonell, Francesco Patti, Samia Joseph Khoury, Mark Slee, Rana Karabudak, Marco Onofrj, Vincent Van Pesch, Julie Prevost, Mastura Monif, Vilija Jokubaitis, Anneke van der Walt, Helmut Butzkueven, MSBase Study Group
J Neurol Neurosurg Psychiatry. 2022 Dec;93(12):1330-1337. doi: 10.1136/jnnp-2022-330104. Epub 2022 Oct 19.

Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry
Sifat Sharmin, Charles B Malpas, Izanne Roos, Ibrahima Diouf, Raed Alroughani, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Dana Horakova, Eva K Havrdova, Francesco Patti, Murat Terzi, Cavit Boz, Bassem Yamout, Samia J Khoury, Marco Onofrj, Alessandra Lugaresi, Ayse Altintas, Alexandre Prat, Marc Girard, Pierre Duquette, Maria José Sá, Daniele La Spitaleri, Youssef Sidhom, Riadh Gouider, Saloua Mrabet, Aysun Soysal, Recai Turkoglu, Maria Pia Amato, Yara D Fragoso, Tomas Kalincik
J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329713. doi: 10.1136/jnnp-2022-329713. Online ahead of print.

Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network
Alessio Signori, Johannes Lorscheider, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Jan Hillert, Robert Hyde, Fabio Pellegrini, Melinda Magyari, Nils Koch-Henriksen, Per Soelberg Sørensen, Tim Spelman, Anneke van der Walt, Dana Horakova, Eva Havrdova, Marc Girard, Sara Eichau, Francois Grand'Maison, Oliver Gerlach, Murat Terzi, Serkan Ozakbas, Olga Skibina, Vincent Van Pesch, Maria Jose Sa, Julie Prevost, Raed Alroughani, Pamela A McCombe, Riadh Gouider, Saloua Mrabet, Tamara Castillo-Trivino, Chao Zhu, Koen de Gans, José Luis Sánchez-Menoyo, Bassem Yamout, Samia Khoury, Maria Pia Sormani, Tomas Kalincik, Helmut Butzkueven, Big MS Data Network
J Neurol Neurosurg Psychiatry. 2022 Sep 28:jnnp-2022-329987. doi: 10.1136/jnnp-2022-329987. Online ahead of print.

Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand
Suzi Claflin, Julie A Campbell, Richard Norman, Deborah F Mason, Tomas Kalincik, Steve Simpson-Yap, Helmut Butzkueven, William M Carroll, Andrew J Palmer, C Leigh Blizzard, Ingrid van der Mei, Glen J Henson, Bruce V Taylor
Eur J Health Econ. 2022 Sep 23. doi: 10.1007/s10198-022-01518-x. Online ahead of print.

Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study
Belinda Cruse, Thanuja Dharmadasa, Elise White, Callum Hollis, Andrew Evans, Sifat Sharmin, Tomas Kalincik, Lynette Kiers
BMJ Neurol Open. 2022 Sep 5;4(2):e000328. doi: 10.1136/bmjno-2022-000328. eCollection 2022.

Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
Steve Simpson-Yap, Ashkan Pirmani, Tomas Kalincik, Edward De Brouwer, Lotte Geys, Tina Parciak, Anne Helme, Nick Rijke, Jan A Hillert, Yves Moreau, Gilles Edan, Sifat Sharmin, Tim Spelman, Robert McBurney, Hollie Schmidt, Arnfin B Bergmann, Stefan Braune, Alexander Stahmann, Rod M Middleton, Amber Salter, Bruce Bebo, Anneke Van der Walt, Helmut Butzkueven, Serkan Ozakbas, Cavit Boz, Rana Karabudak, Raed Alroughani, Juan I Rojas, Ingrid A van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo N Alonso, Richard S Nicholas, Anibal S Chertcoff, Ana Zabalza de Torres, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Liesbet M Peeters
Neurol Neuroimmunol Neuroinflamm. 2022 Aug 29;9(6):e200021. doi: 10.1212/NXI.0000000000200021. Print 2022 Nov.

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Izanne Roos, Charles Malpas, Emmanuelle Leray, Romain Casey, Dana Horakova, Eva Kubala Havrdova, Marc Debouverie, Francesco Patti, Jerome De Seze, Guillermo Izquierdo, Sara Eichau, Gilles Edan, Alexandre Prat, Marc Girard, Serkan Ozakbas, Pierre Grammond, Helene Zephir, Jonathan Ciron, Elisabeth Maillart, Thibault Moreau, Maria Pia Amato, Pierre Labauge, Raed Alroughani, Katherine Buzzard, Olga Skibina, Murat Terzi, David Axel Laplaud, Eric Berger, Francois Grand'Maison, Christine Lebrun-Frenay, Elisabetta Cartechini, Cavit Boz, Jeannette Lechner-Scott, Pierre Clavelou, Bruno Stankoff, Julie Prevost, Ludwig Kappos, Jean Pelletier, Vahid Shaygannejad, Bassem I Yamout, Samia J Khoury, Oliver Gerlach, Daniele L A Spitaleri, Vincent Van Pesch, Olivier Gout, Recai Turkoglu, Olivier Heinzlef, Eric Thouvenot, Pamela Ann McCombe, Aysun Soysal, Bertrand Bourre, Mark Slee, Tamara Castillo-Trivino, Serge Bakchine, Radek Ampapa, Ernest Gerard Butler, Abir Wahab, Richard A Macdonell, Eduardo Aguera-Morales, Philippe Cabre, Nasr Haifa Ben, Anneke Van der Walt, Guy Laureys, Liesbeth Van Hijfte, Cristina M Ramo-Tello, Nicolas Maubeuge, Suzanne Hodgkinson, José Luis Sánchez-Menoyo, Michael H Barnett, Celine Labeyrie, Steve Vucic, Youssef Sidhom, Riadh Gouider, Tunde Csepany, Javier Sotoca, Koen de Gans, Abdullah Al-Asmi, Yara Dadalti Fragoso, Sandra Vukusic, Helmut Butzkueven, Tomas Kalincik, MSBase and OFSEP
Neurology. 2022 Oct 25;99(17):e1926-e1944. doi: 10.1212/WNL.0000000000201029. Epub 2022 Aug 17.

Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
Steve Simpson-Yap, Ashkan Pirmani, Edward De Brouwer, Liesbet M Peeters, Lotte Geys, Tina Parciak, Anne Helme, Jan Hillert, Yves Moreau, Gilles Edan, Tim Spelman, Sifat Sharmin, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Bruce Bebo, Anneke van der Walt, Helmut Butzkueven, Serkan Ozakbas, Rana Karabudak, Cavit Boz, Raed Alroughani, Juan I Rojas, Ingrid van der Mei, Guilherme Sciascia do Olival, Melinda Magyari, Ricardo Alonso, Richard Nicholas, Anibal Chertcoff, Ana Zabalza, Georgina Arrambide, Nupur Nag, Annabel Descamps, Lars Costers, Ruth Dobson, Aleisha Miller, Paulo Rodrigues, Vesna Prčkovska, Giancarlo Comi, Tomas Kalincik
Mult Scler Relat Disord. 2022 Oct;66:104072. doi: 10.1016/j.msard.2022.104072. Epub 2022 Jul 25.

Superior effects of natalizumab versus other DMTs on patient-reported outcomes in people with multiple sclerosis
Jing Chen, Ibrahima Diouf, Bruce V Taylor, Tomas Kalincik, Ingrid van der Mei
J Neurol Neurosurg Psychiatry. 2022 Jul 28:jnnp-2022-329223. doi: 10.1136/jnnp-2022-329223. Online ahead of print.

Prediction of relapse activity when switching to cladribine for multiple sclerosis
Michael Zhong, Anneke van der Walt, Mastura Monif, Suzanne Hodgkinson, Sara Eichau, Tomas Kalincik, Jeannette Lechner-Scott, Katherine Buzzard, Olga Skibina, Vincent Van Pesch, Ernest Butler, Julie Prevost, Marc Girard, Jiwon Oh, Helmut Butzkueven, Vilija Jokubaitis
Mult Scler. 2022 Jul 27:13524585221111677. doi: 10.1177/13524585221111677. Online ahead of print.

Interrogating large multiple sclerosis registries and databases: what information can be gained?
Maria Trojano, Tomas Kalincik, Pietro Iaffaldano, Maria P Amato
Curr Opin Neurol. 2022 Jun 1;35(3):271-277. doi: 10.1097/WCO.0000000000001057.

Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic
Vivien Li, Izanne Roos, Mastura Monif, Charles Malpas, Stefanie Roberts, Mark Marriott, Katherine Buzzard, Ai-Lan Nguyen, Nabil Seery, Lisa Taylor, Tomas Kalincik, Trevor Kilpatrick
Mult Scler Relat Disord. 2022 Jul;63:103913. doi: 10.1016/j.msard.2022.103913. Epub 2022 May 27.

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
M Lefort, S Sharmin, J B Andersen, S Vukusic, R Casey, M Debouverie, G Edan, J Ciron, A Ruet, J De Sèze, E Maillart, H Zephir, P Labauge, G Defer, C Lebrun-Frenay, T Moreau, E Berger, P Clavelou, J Pelletier, B Stankoff, O Gout, E Thouvenot, O Heinzlef, A Al-Khedr, B Bourre, O Casez, P Cabre, A Montcuquet, A Wahab, J P Camdessanché, A Maurousset, H Ben Nasr, K Hankiewicz, C Pottier, N Maubeuge, D Dimitri-Boulos, C Nifle, D A Laplaud, D Horakova, E K Havrdova, R Alroughani, G Izquierdo, S Eichau, S Ozakbas, F Patti, M Onofrj, A Lugaresi, M Terzi, P Grammond, F Grand'Maison, B Yamout, A Prat, M Girard, P Duquette, C Boz, M Trojano, P McCombe, M Slee, J Lechner-Scott, R Turkoglu, P Sola, D Ferraro, F Granella, V Shaygannejad, J Prevost, D Maimone, O Skibina, K Buzzard, A Van der Walt, R Karabudak, B Van Wijmeersch, T Csepany, D Spitaleri, S Vucic, N Koch-Henriksen, F Sellebjerg, P S Soerensen, C C Hilt Christensen, P V Rasmussen, M B Jensen, J L Frederiksen, S Bramow, H K Mathiesen, K I Schreiber, H Butzkueven, M Magyari, T Kalincik, E Leray
BMC Med Res Methodol. 2022 May 30;22(1):155. doi: 10.1186/s12874-022-01623-8.

Confirmed disability progression as a marker of permanent disability in multiple sclerosis
Sifat Sharmin, Francesca Bovis, Charles Malpas, Dana Horakova, Eva Kubala Havrdova, Guillermo Izquierdo, Sara Eichau, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Marco Onofrj, Alessandra Lugaresi, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Murat Terzi, Oliver Gerlach, Raed Alroughani, Cavit Boz, Vahid Shaygannejad, Vincent van Pesch, Elisabetta Cartechini, Ludwig Kappos, Jeannette Lechner-Scott, Roberto Bergamaschi, Recai Turkoglu, Claudio Solaro, Gerardo Iuliano, Franco Granella, Bart Van Wijmeersch, Daniele Spitaleri, Mark Slee, Pamela McCombe, Julie Prevost, Radek Ampapa, Serkan Ozakbas, Jose Luis Sanchez-Menoyo, Aysun Soysal, Steve Vucic, Thor Petersen, Koen de Gans, Ernest Butler, Suzanne Hodgkinson, Youssef Sidhom, Riadh Gouider, Edgardo Cristiano, Tamara Castillo-Triviño, Maria Laura Saladino, Michael Barnett, Fraser Moore, Csilla Rozsa, Bassem Yamout, Olga Skibina, Anneke van der Walt, Katherine Buzzard, Orla Gray, Stella Hughes, Angel Perez Sempere, Bhim Singhal, Yara Fragoso, Cameron Shaw, Allan Kermode, Bruce Taylor, Magdolna Simo, Neil Shuey, Talal Al-Harbi, Richard Macdonell, Jose Andres Dominguez, Tunde Csepany, Carmen Adella Sirbu, Maria Pia Sormani, Helmut Butzkueven, Tomas Kalincik
Eur J Neurol. 2022 Aug;29(8):2321-2334. doi: 10.1111/ene.15406. Epub 2022 Jun 9.

Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy
Adam H Lapidus, Mary Ann Anderson, Simon J Harrison, Michael Dickinson, Tomas Kalincik, Arian Lasocki
Leuk Lymphoma. 2022 Oct;63(10):2364-2374. doi: 10.1080/10428194.2022.2074990. Epub 2022 May 14.

A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours
Joos Meyer, Ibrahima Diouf, James King, Kate Drummond, Stan Stylli, Andrew Kaye, Tomas Kalincik, Helen Danesh-Meyer, R C Andrew Symons
Pituitary. 2022 Aug;25(4):563-572. doi: 10.1007/s11102-022-01228-w. Epub 2022 May 13.

Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study
Marianna Vitkova, Ibrahima Diouf, Charles Malpas, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Vahid Shaygannejad, Marco Onofrj, Alessandra Lugaresi, Raed Alroughani, Alexandre Prat, Catherine Larochelle, Marc Girard, Pierre Duquette, Murat Terzi, Cavit Boz, Francois Grand'Maison, Patrizia Sola, Diana Ferraro, Pierre Grammond, Helmut Butzkueven, Katherine Buzzard, Olga Skibina, Bassem I Yamout, Rana Karabudak, Oliver Gerlach, Jeannette Lechner-Scott, Davide Maimone, Roberto Bergamaschi, Vincent Van Pesch, Gerardo Iuliano, Elisabetta Cartechini, Maria José Sà, Radek Ampapa, Michael Barnett, Stella E Hughes, Cristina M Ramo-Tello, Suzanne Hodgkinson, Daniele L A Spitaleri, Thor Petersen, Ernest Gerard Butler, Mark Slee, Chris McGuigan, Pamela Ann McCombe, Franco Granella, Edgardo Cristiano, Julie Prevost, Bruce V Taylor, Josã Luis Sãnchez-Menoyo, Guy Laureys, Liesbeth Van Hijfte, Steve Vucic, Richard A Macdonell, Orla Gray, Javier Olascoaga, Norma Deri, Yara Dadalti Fragoso, Cameron Shaw, Tomas Kalincik, MSBase Study Group
Neurology. 2022 Jun 14;98(24):e2401-e2412. doi: 10.1212/WNL.0000000000200545. Epub 2022 Apr 11.

Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS
Tomas Kalincik, Ilya Kister, Tamar E Bacon, Charles B Malpas, Sifat Sharmin, Dana Horakova, Eva Kubala-Havrdova, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Serkan Ozakbas, Marco Onofrj, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Patrizia Sola, Diana Ferraro, Raed Alroughani, Murat Terzi, Cavit Boz, Francois Grand'Maison, Roberto Bergamaschi, Oliver Gerlach, Maria J Sa, Ludwig Kappos, Elisabetta Cartechini, Jeannette Lechner-Scott, Vincent van Pesch, Vahid Shaygannejad, Franco Granella, Daniele Spitaleri, Gerardo Iuliano, Davide Maimone, Julie Prevost, Aysun Soysal, Recai Turkoglu, Radek Ampapa, Helmut Butzkueven, Gary Cutter, for MSBase Study Group
Mult Scler. 2022 Oct;28(11):1752-1761. doi: 10.1177/13524585221084577. Epub 2022 Apr 3.

Multiple Sclerosis Relapses Following Cessation of Fingolimod
Charles B Malpas, Izanne Roos, Sifat Sharmin, Katherine Buzzard, Olga Skibina, Helmut Butzkueven, Ludwig Kappos, Francesco Patti, Raed Alroughani, Dana Horakova, Eva Kubala Havrdova, Guillermo Izquierdo, Sara Eichau, Suzanne Hodgkinson, Pierre Grammond, Jeannette Lechner-Scott, Tomas Kalincik, MSBase Study Group
Clin Drug Investig. 2022 Apr;42(4):355-364. doi: 10.1007/s40261-022-01129-7. Epub 2022 Mar 18.

The dynamics of relapses during treatment switch in relapsing-remitting multiple sclerosis
Federico Frascoli, Izanne Roos, Charles B Malpas, Tomas Kalincik
J Theor Biol. 2022 May 21;541:111091. doi: 10.1016/j.jtbi.2022.111091. Epub 2022 Mar 11.

Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome
James D Triplett, Jessica Qiu, Billy O'Brien, Sumana Gopinath, Benjamin Trewin, Penelope J Spring, Mohamed Shaffi, Jerome Ip, Fiona Chan, Luke Chen, Ian Wilson, Claire Muller, Heidi N Beadnall, Mike Boggild, Anneke Van der Walt, Richard Roxburgh, Nabil Seery, Tomas Kalincik, Michael H Barnett, John D E Parratt, Stephen W Reddel, Benjamin Tsang, Todd A Hardy
Eur J Neurol. 2022 Jun;29(6):1771-1781. doi: 10.1111/ene.15317. Epub 2022 Mar 25.

Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study
G Saposnik, S Andhavarapu, Ó Fernández, H J Kim, H Wiendl, M Foss, F Zuo, E K Havrdová, E Celius, F Caceres, M Magyari, R Bermel, A Costa, M Terzaghi, T Kalincik, V Popescu, M P Amato, X Montalban, J Oh
Mult Scler Relat Disord. 2022 Feb;58:103404. doi: 10.1016/j.msard.2021.103404. Epub 2021 Nov 16.

Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive tests
Daniel Merlo, Tomas Kalincik, Chao Zhu, Melissa Gresle, Jeannette Lechner-Scott, Trevor Kilpatrick, Michael Barnett, Bruce Taylor, Katherine Buzzard, David Darby, Helmut Butzkueven, Anneke van der Walt
Mult Scler Relat Disord. 2022 Feb;58:103393. doi: 10.1016/j.msard.2021.103393. Epub 2021 Nov 10.

Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives
Dhamidhu Eratne, Shorena Janelidze, Charles B Malpas, Samantha Loi, Mark Walterfang, Antonia Merritt, Ibrahima Diouf, Kaj Blennow, Henrik Zetterberg, Brandon Cilia, Cassandra Wannan, Chad Bousman, Ian Everall, Andrew Zalesky, Mahesh Jayaram, Naveen Thomas, Samuel F Berkovic, Oskar Hansson, Dennis Velakoulis, Christos Pantelis, Alexander Santillo, MiND Study Group
Aust N Z J Psychiatry. 2022 Oct;56(10):1295-1305. doi: 10.1177/00048674211058684. Epub 2021 Nov 17.

Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists
Gustavo Saposnik, Sanketh Andhavarapu, Óscar Fernández, Ho Jin Kim, Heinz Wiendl, Mona Foss, Fei Zuo, Eva Kubala Havrdová, Elisabeth Gulowsen Celius, Fernando Caceres, Melinda Magyari, Robert Bermel, Andreia Costa, Maria Terzaghi, Tomas Kalincik, Veronica Popescu, Maria Pia Amato, Xavier Montalban, Jiwon Oh
Mult Scler Relat Disord. 2022 Jan;57:103389. doi: 10.1016/j.msard.2021.103389. Epub 2021 Nov 13.

Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom
Timothy Spelman, William L Herring, Yuanhui Zhang, Michael Tempest, Isobel Pearson, Ulrich Freudensprung, Carlos Acosta, Thibaut Dort, Robert Hyde, Eva Havrdova, Dana Horakova, Maria Trojano, Giovanna De Luca, Alessandra Lugaresi, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Raed Alroughani, Eugenio Pucci, Franco Granella, Jeannette Lechner-Scott, Patrizia Sola, Diana Ferraro, Francois Grand'Maison, Murat Terzi, Csilla Rozsa, Cavit Boz, Raymond Hupperts, Vincent Van Pesch, Celia Oreja-Guevara, Anneke van der Walt, Vilija G Jokubaitis, Tomas Kalincik, Helmut Butzkueven, MSBase Investigators
Pharmacoeconomics. 2022 Mar;40(3):323-339. doi: 10.1007/s40273-021-01106-6. Epub 2021 Dec 18.

Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180]
Edward De Brouwer, Thijs Becker, Yves Moreau, Eva Kubala Havrdova, Maria Trojano, Sara Eichau, Serkan Ozakbas, Marco Onofrj, Pierre Grammond, Jens Kuhle, Ludwig Kappos, Patrizia Sola, Elisabetta Cartechini, Jeannette Lechner-Scott, Raed Alroughani, Oliver Gerlach, Tomas Kalincik, Franco Granella, Francois Grand'Maison, Roberto Bergamaschi, Maria José Sá, Bart Van Wijmeersch, Aysun Soysal, Jose Luis Sanchez-Menoyo, Claudio Solaro, Cavit Boz, Gerardo Iuliano, Katherine Buzzard, Eduardo Aguera-Morales, Murat Terzi, Tamara Castillo Trivio, Daniele Spitaleri, Vincent Van Pesch, Vahid Shaygannejad, Fraser Moore, Celia Oreja-Guevara, Davide Maimone, Riadh Gouider, Tunde Csepany, Cristina Ramo-Tello, Liesbet Peeters
Comput Methods Programs Biomed. 2022 Jan;213:106479. doi: 10.1016/j.cmpb.2021.106479. Epub 2021 Nov 5.

High BMI in Youths as a Modifiable Risk Factor for Multiple Sclerosis: Weighing Up the Evidence
Tomas Kalincik, Helen Tremlett, Alberto Ascherio
Neurology. 2021 Dec 7;97(23):1057-1058. doi: 10.1212/WNL.0000000000012966. Epub 2021 Oct 25.

Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
Vicki E Maltby, Rodney A Lea, Mastura Monif, Marzena J Fabis-Pedrini, Katherine Buzzard, Tomas Kalincik, Allan G Kermode, Bruce Taylor, Suzanne Hodgkinson, Pamela McCombe, Helmut Butzkueven, Michael Barnett, Jeannette Lechner-Scott
JMIR Res Protoc. 2021 Oct 19;10(10):e24969. doi: 10.2196/24969.

Prediction of multiple sclerosis outcomes when switching to ocrelizumab
Michael Zhong, Anneke van der Walt, Jim Stankovich, Tomas Kalincik, Katherine Buzzard, Olga Skibina, Cavit Boz, Suzanne Hodgkinson, Mark Slee, Jeannette Lechner-Scott, Richard Macdonell, Julie Prevost, Jens Kuhle, Guy Laureys, Liesbeth Van Hijfte, Raed Alroughani, Allan G Kermode, Ernest Butler, Michael Barnett, Sara Eichau, Vincent van Pesch, Pierre Grammond, Pamela McCombe, Rana Karabudak, Pierre Duquette, Marc Girard, Bruce Taylor, Wei Yeh, Mastura Monif, Melissa Gresle, Helmut Butzkueven, Vilija G Jokubaitis
Mult Scler. 2022 May;28(6):958-969. doi: 10.1177/13524585211049986. Epub 2021 Oct 8.

Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis
Tomas Uher, Eva Kubala Havrdova, Pascal Benkert, Niels Bergsland, Jan Krasensky, Barbora Srpova, Michael Dwyer, Michaela Tyblova, Stephanie Meier, Manuela Vaneckova, Dana Horakova, Robert Zivadinov, David Leppert, Tomas Kalincik, Jens Kuhle
Mult Scler. 2021 Nov;27(13):2001-2013. doi: 10.1177/13524585211047977. Epub 2021 Oct 6.

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
Steve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, Nick Rijke, Jan A Hillert, Clare Walton, Gilles Edan, Yves Moreau, Tim Spelman, Lotte Geys, Tina Parciak, Clement Gautrais, Nikola Lazovski, Ashkan Pirmani, Amin Ardeshirdavanai, Lars Forsberg, Anna Glaser, Robert McBurney, Hollie Schmidt, Arnfin B Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Robert J Fox, Anneke van der Walt, Helmut Butzkueven, Raed Alroughani, Serkan Ozakbas, Juan I Rojas, Ingrid van der Mei, Nupur Nag, Rumen Ivanov, Guilherme Sciascia do Olival, Alice Estavo Dias, Melinda Magyari, Doralina Brum, Maria Fernanda Mendes, Ricardo N Alonso, Richard S Nicholas, Johana Bauer, Aníbal Sebastián Chertcoff, Anna Zabalza, Georgina Arrambide, Alexander Fidao, Giancarlo Comi, Liesbet Peeters
Neurology. 2021 Nov 9;97(19):e1870-e1885. doi: 10.1212/WNL.0000000000012753. Epub 2021 Oct 5.

Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis
Daniel Merlo, Jim Stankovich, Claire Bai, Tomas Kalincik, Chao Zhu, Melissa Gresle, Jeannette Lechner-Scott, Trevor Kilpatrick, Michael Barnett, Bruce Taylor, David Darby, Helmut Butzkueven, Anneke Van der Walt
Neurology. 2021 Nov 16;97(20):e2020-e2031. doi: 10.1212/WNL.0000000000012850. Epub 2021 Sep 23.

Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry
Rachel Kenney, Mengling Liu, Sachi Patil, Raed Alroughani, Radek Ampapa, Roberto Bergamaschi, Cavit Boz, Helmut Butzkueven, Jose Cabrera Gomez, Elisabetta Cartechini, Sara Eichau Madueño, Diana Ferraro, Francois Grand-Maison, Franco Granella, Dana Horakova, Guillermo Izquierdo Ayuso, Tomas Kalincik, Jana Lizrova Preiningerova, Alessandra Lugaresi, Marco Onofrj, Serkan Ozakbas, Francesco Patti, Patrizia Sola, Aysun Soysal, Daniele Litterio A Spitaleri, Murat Terzi, Recai Turkoglu, Vincent van Pesch, Shiv Saidha, Lorna E Thorpe, Steven L Galetta, Laura J Balcer, Ilya Kister, Tim Spelman, MSBase Study Group
J Neurol Sci. 2021 Nov 15;430:118067. doi: 10.1016/j.jns.2021.118067. Epub 2021 Sep 3.

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
Sifat Sharmin, Mathilde Lefort, Johanna Balslev Andersen, Emmanuelle Leray, Dana Horakova, Eva Kubala Havrdova, Raed Alroughani, Guillermo Izquierdo, Serkan Ozakbas, Francesco Patti, Marco Onofrj, Alessandra Lugaresi, Murat Terzi, Pierre Grammond, Francois Grand'Maison, Bassem Yamout, Alexandre Prat, Marc Girard, Pierre Duquette, Cavit Boz, Maria Trojano, Pamela McCombe, Mark Slee, Jeannette Lechner-Scott, Recai Turkoglu, Patrizia Sola, Diana Ferraro, Franco Granella, Julie Prevost, Davide Maimone, Olga Skibina, Katherine Buzzard, Anneke Van der Walt, Bart Van Wijmeersch, Tunde Csepany, Daniele Spitaleri, Steve Vucic, Romain Casey, Marc Debouverie, Gilles Edan, Jonathan Ciron, Aurélie Ruet, Jérôme De Sèze, Elisabeth Maillart, Hélène Zephir, Pierre Labauge, Gilles Defer, Christine Lebrun-Frénay, Thibault Moreau, Eric Berger, Pierre Clavelou, Jean Pelletier, Bruno Stankoff, Olivier Gout, Eric Thouvenot, Olivier Heinzlef, Abullatif Al-Khedr, Bertrand Bourre, Olivier Casez, Philippe Cabre, Alexis Montcuquet, Abir Wahab, Jean-Philippe Camdessanché, Aude Maurousset, Ivania Patry, Karolina Hankiewicz, Corinne Pottier, Nicolas Maubeuge, Céline Labeyrie, Chantal Nifle, David Laplaud, Niels Koch-Henriksen, Finn Thorup Sellebjerg, Per Soelberg Soerensen, Claudia Christina Pfleger, Peter Vestergaard Rasmussen, Michael Broksgaard Jensen, Jette Lautrup Frederiksen, Stephan Bramow, Henrik Kahr Mathiesen, Karen Ingrid Schreiber, Melinda Magyari, Sandra Vukusic, Helmut Butzkueven, Tomas Kalincik, Danish Multiple Sclerosis Registry, OFSEP and the MSBase investigators
CNS Drugs. 2021 Nov;35(11):1217-1232. doi: 10.1007/s40263-021-00860-7. Epub 2021 Sep 18.

Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study
Michael Barnett, Niels Bergsland, Bianca Weinstock-Guttman, Helmut Butzkueven, Tomas Kalincik, Patricia Desmond, Frank Gaillard, Vincent van Pesch, Serkan Ozakbas, Juan Ignacio Rojas, Cavit Boz, Ayse Altintas, Chenyu Wang, Michael G Dwyer, Suzie Yang, Dejan Jakimovski, Kain Kyle, Deepa P Ramasamy, Robert Zivadinov
Neuroimage Clin. 2021;32:102802. doi: 10.1016/j.nicl.2021.102802. Epub 2021 Aug 24.

The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis
Suzi B Claflin, Julie A Campbell, Deborah F Mason, Tomas Kalincik, Steve Simpson-Yap, Richard Norman, Helmut Butzkueven, William M Carroll, Andrew J Palmer, C Leigh Blizzard, Ingrid van der Mei, Bruce V Taylor
Mult Scler. 2022 Apr;28(5):831-841. doi: 10.1177/13524585211035948. Epub 2021 Aug 13.

Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis
Izanne Roos, Emmanuelle Leray, Romain Casey, Dana Horakova, Eva Havrdova, Guillermo Izquierdo, Sara Eichau Madueño, Francesco Patti, Gilles Edan, Marc Debouverie, Jean Pelletier, Serkan Ozakbas, Maria Pia Amato, Pierre Clavelou, Pierre Grammond, Cavit Boz, Katherine Buzzard, Olga Skibina, Jonathan Ciron, Oliver Gerlach, Francois Grand'Maison, Jeannette Lechner-Scott, Charles Malpas, Helmut Butzkueven, Sandra Vukusic, Tomas Kalincik, MSBase and OFSEP Study Groups
Neurology. 2021 Aug 31;97(9):e869-e880. doi: 10.1212/WNL.0000000000012354. Epub 2021 Jun 30.

Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018
Nahid Moradi, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Vahid Shaygannejad, Murat Terzi, Cavit Boz, Bassem Yamout, Recai Turkoglu, Rana Karabudak, Sherif Hamdy, Aysun Soysal, Ayşe Altıntaş, Jihad Inshasi, Talal Al-Harbi, Raed Alroughani, Tomas Kalincik, MSBase Study Group
CNS Drugs. 2021 Oct;35(10):1097-1106. doi: 10.1007/s40263-021-00833-w. Epub 2021 Jun 23.

Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression
Edward De Brouwer, Thijs Becker, Yves Moreau, Eva Kubala Havrdova, Maria Trojano, Sara Eichau, Serkan Ozakbas, Marco Onofrj, Pierre Grammond, Jens Kuhle, Ludwig Kappos, Patrizia Sola, Elisabetta Cartechini, Jeannette Lechner-Scott, Raed Alroughani, Oliver Gerlach, Tomas Kalincik, Franco Granella, Francois Grand'Maison, Roberto Bergamaschi, Maria José Sá, Bart Van Wijmeersch, Aysun Soysal, Jose Luis Sanchez-Menoyo, Claudio Solaro, Cavit Boz, Gerardo Iuliano, Katherine Buzzard, Eduardo Aguera-Morales, Murat Terzi, Tamara Castillo Trivio, Daniele Spitaleri, Vincent Van Pesch, Vahid Shaygannejad, Fraser Moore, Celia Oreja-Guevara, Davide Maimone, Riadh Gouider, Tunde Csepany, Cristina Ramo-Tello, Liesbet Peeters
Comput Methods Programs Biomed. 2021 Sep;208:106180. doi: 10.1016/j.cmpb.2021.106180. Epub 2021 May 18.

Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
Saúl Reyes, Anthony L Cunningham, Tomas Kalincik, Eva Kubala Havrdová, Noriko Isobe, Julia Pakpoor, Laura Airas, Reem F Bunyan, Anneke van der Walt, Jiwon Oh, Joela Mathews, Farrah J Mateen, Gavin Giovannoni
J Neuroimmunol. 2021 Aug 15;357:577627. doi: 10.1016/j.jneuroim.2021.577627. Epub 2021 Jun 7.

The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies
Johanna B Andersen, Sifat Sharmin, Mathilde Lefort, Nils Koch-Henriksen, Finn Sellebjerg, Per Soelberg Sørensen, Claudia C Hilt Christensen, Peter V Rasmussen, Michael B Jensen, Jette L Frederiksen, Stephan Bramow, Henrik K Mathiesen, Karen I Schreiber, Dana Horakova, Eva K Havrdova, Raed Alroughani, Guillermo Izquierdo, Sara Eichau, Serkan Ozakbas, Francesco Patti, Marco Onofrj, Alessandra Lugaresi, Murat Terzi, Pierre Grammond, Francois Grand Maison, Bassem Yamout, Alexandre Prat, Marc Girard, Pierre Duquette, Cavit Boz, Maria Trojano, Pamela McCombe, Mark Slee, Jeannette Lechner-Scott, Recai Turkoglu, Patrizia Sola, Diana Ferraro, Franco Granella, Vahid Shaygannejad, Julie Prevost, Olga Skibina, Claudio Solaro, Rana Karabudak, Bart V Wijmeersch, Tunde Csepany, Daniele Spitaleri, Steve Vucic, Romain Casey, Marc Debouverie, Gilles Edan, Jonathan Ciron, Aurélie Ruet, Jérôme D Sèze, Elisabeth Maillart, Hélène Zephir, Pierre Labauge, Gilles Defer, Christine Lebrun, Thibault Moreau, Eric Berger, Pierre Clavelou, Jean Pelletier, Bruno Stankoff, Olivier Gout, Eric Thouvenot, Olivier Heinzlef, Abdullatif Al-Khedr, Bertrand Bourre, Olivier Casez, Philippe Cabre, Alexis Montcuquet, Abir Wahab, Jean-Philippe Camdessanché, Aude Marousset, Ivania Patry, Karolina Hankiewicz, Corinne Pottier, Nicolas Maubeuge, Céline Labeyrie, Chantal Nifle, Emmanuelle Leray, David A Laplaud, Helmut Butzkueven, Tomas Kalincik, Sandra Vukusic, Melinda Magyari
Mult Scler Relat Disord. 2021 Aug;53:103012. doi: 10.1016/j.msard.2021.103012. Epub 2021 May 8.

Lesser-Known Aspects of Deep Brain Stimulation for Parkinson's Disease: Programming Sessions, Hardware Surgeries, Residential Care Admissions, and Deaths
San San Xu, Charles B Malpas, Kristian J Bulluss, Hugh J McDermott, Tomas Kalincik, Wesley Thevathasan
Neuromodulation. 2022 Aug;25(6):836-845. doi: 10.1111/ner.13466. Epub 2022 Jun 14.

Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Wei Zhen Yeh, Putu Ayu Widyastuti, Anneke Van der Walt, Jim Stankovich, Eva Havrdova, Dana Horakova, Karolina Vodehnalova, Serkan Ozakbas, Sara Eichau, Pierre Duquette, Tomas Kalincik, Francesco Patti, Cavit Boz, Murat Terzi, Bassem I Yamout, Jeannette Lechner-Scott, Patrizia Sola, Olga G Skibina, Michael Barnett, Marco Onofrj, Maria José Sá, Pamela Ann McCombe, Pierre Grammond, Radek Ampapa, Francois Grand'Maison, Roberto Bergamaschi, Daniele L A Spitaleri, Vincent Van Pesch, Elisabetta Cartechini, Suzanne Hodgkinson, Aysun Soysal, Albert Saiz, Melissa Gresle, Tomas Uher, Davide Maimone, Recai Turkoglu, Raymond Mm Hupperts, Maria Pia Amato, Franco Granella, Celia Oreja-Guevara, Ayse Altintas, Richard A Macdonell, Tamara Castillo-Trivino, Helmut Butzkueven, Raed Alroughani, Vilija G Jokubaitis, MSBase Study Group
Neurology. 2021 Apr 20;96(24):e2989-3002. doi: 10.1212/WNL.0000000000012084. Online ahead of print.

Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
Nabil Seery, Sifat Sharmin, Vivien Li, Ai-Lan Nguyen, Claire Meaton, Roberts Atvars, Nicola Taylor, Kelsey Tunnell, John Carey, Mark P Marriott, Katherine A Buzzard, Izanne Roos, Chris Dwyer, Josephine Baker, Lisa Taylor, Kymble Spriggs, Trevor J Kilpatrick, Tomas Kalincik, Mastura Monif
CNS Drugs. 2021 Aug;35(8):907-918. doi: 10.1007/s40263-021-00810-3. Epub 2021 Apr 13.

Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis
Tomas Uher, Jan Krasensky, Charles Malpas, Niels Bergsland, Michael G Dwyer, Eva Kubala Havrdova, Manuela Vaneckova, Dana Horakova, Robert Zivadinov, Tomas Kalincik
Neurol Neuroimmunol Neuroinflamm. 2021 Mar 16;8(3):e979. doi: 10.1212/NXI.0000000000000979. Print 2021 May.

The prevalence of epileptic seizures in multiple sclerosis in a large tertiary hospital in Australia
Suyi Ooi, Tomas Kalincik, Piero Perucca, Mastura Monif
Mult Scler J Exp Transl Clin. 2021 Feb 24;7(1):2055217321989767. doi: 10.1177/2055217321989767. eCollection 2021 Jan-Mar.

Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis
James Broadley, Robb Wesselingh, Udaya Seneviratne, Chris Kyndt, Paul Beech, Katherine Buzzard, Cassie Nesbitt, Wendyl D'souza, Amy Brodtmann, Richard Macdonell, Tomas Kalincik, Helmut Butzkueven, Terence J O'Brien, Mastura Monif, Australian Autoimmune Encephalitis Consortium
J Neuroimmunol. 2021 Apr 15;353:577508. doi: 10.1016/j.jneuroim.2021.577508. Epub 2021 Jan 30.

Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium
James Broadley, Robb Wesselingh, Udaya Seneviratne, Chris Kyndt, Paul Beech, Katherine Buzzard, Cassie Nesbitt, Wendyl D'Souza, Amy Brodtmann, Tomas Kalincik, Helmut Butzkueven, Terence J O'Brien, Mastura Monif, Australian Autoimmune Encephalitis Consortium
Front Immunol. 2021 Jan 14;11:597858. doi: 10.3389/fimmu.2020.597858. eCollection 2020.

Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS
Andrew Chan, John Rose, Enrique Alvarez, Amit Bar-Or, Helmut Butzkueven, Robert J Fox, Ralf Gold, Mark Gudesblatt, Jodi Haartsen, Tim Spelman, Katy Wright, Diana Ferraro, Patrizia Sola, Suzanne Hodgkinson, Tomas Kalincik, Jeannette Lechner-Scott, Christopher McGuigan, Karen Spach, Chongshu Chen, Sami Fam, Fan Wu, Catherine Miller
Neurol Clin Pract. 2020 Dec;10(6):510-519. doi: 10.1212/CPJ.0000000000000800.

Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study
Mathias Due Buron, Tomas Kalincik, Finn Sellebjerg, Per Soelberg Sørensen, Melinda Magyari
J Neurol Neurosurg Psychiatry. 2021 May;92(5):556-562. doi: 10.1136/jnnp-2020-324869. Epub 2021 Jan 12.

Determinants of therapeutic lag in multiple sclerosis
Izanne Roos, Emmanuelle Leray, Federico Frascoli, Romain Casey, J William L Brown, Dana Horakova, Eva Kubala Havrdova, Marc Debouverie, Maria Trojano, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Gilles Edan, Alexandre Prat, Marc Girard, Pierre Duquette, Marco Onofrj, Alessandra Lugaresi, Pierre Grammond, Jonathan Ciron, Aurélie Ruet, Serkan Ozakbas, Jérôme De Seze, Céline Louapre, Hélène Zephir, Maria José Sá, Patrizia Sola, Diana Ferraro, Pierre Labauge, Gilles Defer, Roberto Bergamaschi, Christine Lebrun-Frenay, Cavit Boz, Elisabetta Cartechini, Thibault Moreau, David Laplaud, Jeannette Lechner-Scott, Francois Grand'Maison, Oliver Gerlach, Murat Terzi, Franco Granella, Raed Alroughani, Gerardo Iuliano, Vincent Van Pesch, Bart Van Wijmeersch, Daniele LA Spitaleri, Aysun Soysal, Eric Berger, Julie Prevost, Eduardo Aguera-Morales, Pamela McCombe, Tamara Castillo Triviño, Pierre Clavelou, Jean Pelletier, Recai Turkoglu, Bruno Stankoff, Olivier Gout, Eric Thouvenot, Olivier Heinzlef, Youssef Sidhom, Riadh Gouider, Tunde Csepany, Bertrand Bourre, Abdullatif Al Khedr, Olivier Casez, Philippe Cabre, Alexis Montcuquet, Abir Wahab, Jean-Philippe Camdessanche, Aude Maurousset, Ivania Patry, Karolina Hankiewicz, Corinne Pottier, Nicolas Maubeuge, Céline Labeyrie, Chantal Nifle, Alasdair Coles, Charles B Malpas, Sandra Vukusic, Helmut Butzkueven, Tomas Kalincik
Mult Scler. 2021 Oct;27(12):1838-1851. doi: 10.1177/1352458520981300. Epub 2021 Jan 11.

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years
Tomas Kalincik, Ibrahima Diouf, Sifat Sharmin, Charles Malpas, Tim Spelman, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Vilija Jokubaitis, Anneke van der Walt, Francois Grand'Maison, Patrizia Sola, Diana Ferraro, Vahid Shaygannejad, Raed Alroughani, Raymond Hupperts, Murat Terzi, Cavit Boz, Jeannette Lechner-Scott, Eugenio Pucci, Vincent Van Pesch, Franco Granella, Roberto Bergamaschi, Daniele Spitaleri, Mark Slee, Steve Vucic, Radek Ampapa, Pamela McCombe, Cristina Ramo-Tello, Julie Prevost, Javier Olascoaga, Edgardo Cristiano, Michael Barnett, Maria Laura Saladino, Jose Luis Sanchez-Menoyo, Suzanne Hodgkinson, Csilla Rozsa, Stella Hughes, Fraser Moore, Cameron Shaw, Ernest Butler, Olga Skibina, Orla Gray, Allan Kermode, Tunde Csepany, Bhim Singhal, Neil Shuey, Imre Piroska, Bruce Taylor, Magdolna Simo, Carmen-Adella Sirbu, Attila Sas, Helmut Butzkueven, MSBase Study Group
Neurology. 2021 Feb 2;96(5):e783-e797. doi: 10.1212/WNL.0000000000011242. Epub 2020 Dec 28.

Adverse events related to antiepileptic drugs
Yew Li Dang, Emma Foster, Michael Lloyd, Genevieve Rayner, Maria Rychkova, Rashida Ali, Patrick W Carney, Dennis Velakoulis, Toby T Winton-Brown, Tomas Kalincik, Piero Perucca, Terence J O'Brien, Patrick Kwan, Charles B Malpas
Epilepsy Behav. 2021 Feb;115:107657. doi: 10.1016/j.yebeh.2020.107657. Epub 2020 Dec 22.

Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic
Louise Rath, Minh Viet Bui, Julian Ellis, John Carey, Josephine Baker, Lisa Taylor, Hasini Fernando, Nicola Taylor, Poppy Savage, Janene Richards, Michael Zhong, Tomas Kalincik, Olga Skibina, Robb Wesselingh, Ai-Lan Nguyen, Mastura Monif, Helmut Butzkueven, Anneke van der Walt
Mult Scler Relat Disord. 2021 Jan;47:102642. doi: 10.1016/j.msard.2020.102642. Epub 2020 Dec 1.

A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia
Lucy Vivash, Charles B Malpas, Leonid Churilov, Mark Walterfang, Amy Brodtmann, Olivier Piguet, Rebekah M Ahmed, Ashley I Bush, Christopher M Hovens, T Kalincik, David Darby, Dennis Velakoulis, Terence J O'Brien
BMJ Open. 2020 Nov 16;10(11):e040100. doi: 10.1136/bmjopen-2020-040100.

Reply: Aggressive multiple sclerosis: a matter of measurement and timing
Tomas Kalincik, Charles B Malpas
Brain. 2020 Dec 5;143(11):e98. doi: 10.1093/brain/awaa307.

Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?
Tomas Kalincik, Maria Pia Sormani, Carmen Tur
Neurology. 2021 Jan 5;96(1):12-13. doi: 10.1212/WNL.0000000000011120. Epub 2020 Oct 26.

Correction to: Serum microRNA is a biomarker for post-operative monitoring in glioma
Andrew Morokoff, Jordan Jones, Hong Nguyen, Chenkai Ma, Arian Lasocki, Frank Gaillard, Iwan Bennett, Rod Luwor, Stanley Stylli, Lucia Paradiso, Rachel Koldej, Iddo Paldor, Ramyar Molania, Terence P Speed, Andrew Webb, Guiseppe Infusini, Jason Li, Charles Malpas, Tomas Kalincik, Katharine Drummond, Tali Siegal, Andrew H Kaye
J Neurooncol. 2020 Sep;149(3):401. doi: 10.1007/s11060-020-03630-5.

Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a
Francesca Bovis, Tomas Kalincik, Fred Lublin, Gary Cutter, Charles Malpas, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Marco Onofrj, Alessandra Lugaresi, Guillermo Izquierdo, Sara Eichau, Francesco Patti, Murat Terzi, Pierre Grammond, Roberto Bergamaschi, Patrizia Sola, Diana Ferraro, Serkan Ozakbas, Gerardo Iuliano, Cavit Boz, Raymond Hupperts, Francois Grand'Maison, Celia Oreja-Guevara, Vincent van Pesch, Elisabetta Cartechini, Thor Petersen, Ayse Altintas, Aysun Soysal, Cristina Ramo-Tello, Pamela McCombe, Recai Turkoglu, Helmut Butzkueven, Jerry S Wolinsky, Claudio Solaro, Maria Pia Sormani
Neurology. 2021 Jan 12;96(2):e214-e227. doi: 10.1212/WNL.0000000000010991. Epub 2020 Oct 6.

Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia
Nabil Seery, Vivien Li, Ai-Lan Nguyen, Izanne Roos, Katherine A Buzzard, Roberts Atvars, Nicola Taylor, Kelsey Tunnell, John Carey, Chris Dwyer, Hasini Fernandoa Lisa Taylor, Josephine Baker, Mark P Marriott, Trevor J Kilpatrick, Tomas Kalincik, Mastura Monif
Mult Scler Relat Disord. 2020 Nov;46:102516. doi: 10.1016/j.msard.2020.102516. Epub 2020 Sep 16.

Delay from treatment start to full effect of immunotherapies for multiple sclerosis
Izanne Roos, Emmanuelle Leray, Federico Frascoli, Romain Casey, J William L Brown, Dana Horakova, Eva K Havrdova, Maria Trojano, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Marco Onofrj, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Grammond, Patrizia Sola, Diana Ferraro, Serkan Ozakbas, Roberto Bergamaschi, Maria José Sá, Elisabetta Cartechini, Cavit Boz, Franco Granella, Raymond Hupperts, Murat Terzi, Jeannette Lechner-Scott, Daniele Spitaleri, Vincent Van Pesch, Aysun Soysal, Javier Olascoaga, Julie Prevost, Eduardo Aguera-Morales, Mark Slee, Tunde Csepany, Recai Turkoglu, Youssef Sidhom, Riadh Gouider, Bart Van Wijmeersch, Pamela McCombe, Richard Macdonell, Alasdair Coles, Charles B Malpas, Helmut Butzkueven, Sandra Vukusic, Tomas Kalincik, MSBase, OFSEP investigators
Brain. 2020 Sep 1;143(9):2742-2756. doi: 10.1093/brain/awaa231.

Comparative effectiveness of rituximab in multiple sclerosis
Tomas Kalincik, Maria Pia Sormani
Nat Rev Neurol. 2021 Jan;17(1):3-4. doi: 10.1038/s41582-020-00412-5.

Association of Pregnancy With the Onset of Clinically Isolated Syndrome
Ai-Lan Nguyen, Karolina Vodehnalova, Tomas Kalincik, Alessio Signori, Eva Kubala Havrdova, Jeannette Lechner-Scott, Olga G Skibina, Alana Eastaugh, Lisa Taylor, Josephine Baker, Nicola McGuinn, Louise Rath, Vicki Maltby, Maria Pia Sormani, Helmut Butzkueven, Anneke Van der Walt, Dana Horakova, Vilija G Jokubaitis
JAMA Neurol. 2020 Dec 1;77(12):1496-1503. doi: 10.1001/jamaneurol.2020.3324.

Serum microRNA is a biomarker for post-operative monitoring in glioma
Andrew Morokoff, Jordan Jones, Hong Nguyen, Chenkai Ma, Arian Lasocki, Frank Gaillard, Iwan Bennett, Rod Luwor, Stanley Stylli, Lucia Paradiso, Rachel Koldej, Iddo Paldor, Ramyar Molania, Terence P Speed, Andrew Webb, Guiseppe Infusini, Jason Li, Charles Malpas, Tomas Kalincik, Katharine Drummond, Tali Siegal, Andrew H Kaye
J Neurooncol. 2020 Sep;149(3):391-400. doi: 10.1007/s11060-020-03566-w. Epub 2020 Sep 11.

Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis
Nathaniel Lizak, Charles B Malpas, Sifat Sharmin, Eva Kubala Havrdova, Dana Horakova, Guillermo Izquierdo, Sara Eichau, Alessandra Lugaresi, Pierre Duquette, Marc Girard, Alexandre Prat, Catherine Larochelle, Maria Trojano, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Raymond Hupperts, Roberto Bergamaschi, Cavit Boz, Vincent Van Pesch, Daniele Spitaleri, Murat Terzi, Tomas Kalincik, MSBase Study Group
JAMA Neurol. 2020 Nov 1;77(11):1398-1407. doi: 10.1001/jamaneurol.2020.2453.

COVID-19 in people with multiple sclerosis: A global data sharing initiative
Liesbet M Peeters, Tina Parciak, Clare Walton, Lotte Geys, Yves Moreau, Edward De Brouwer, Daniele Raimondi, Ashkan Pirmani, Tomas Kalincik, Gilles Edan, Steve Simpson-Yap, Luc De Raedt, Yann Dauxais, Clément Gautrais, Paulo R Rodrigues, Landon McKenna, Nikola Lazovski, Jan Hillert, Lars Forsberg, Tim Spelman, Robert McBurney, Hollie Schmidt, Arnfin Bergmann, Stefan Braune, Alexander Stahmann, Rodden Middleton, Amber Salter, Bruce F Bebo, Juan I Rojas, Anneke van der Walt, Helmut Butzkueven, Ingrid van der Mei, Rumen Ivanov, Kerstin Hellwig, Guilherme Sciascia do Olival, Jeffrey A Cohen, Wim Van Hecke, Ruth Dobson, Melinda Magyari, Doralina Guimarães Brum, Ricardo Alonso, Richard Nicholas, Johana Bauer, Anibal Chertcoff, Jérôme de Sèze, Céline Louapre, Giancarlo Comi, Nick Rijke
Mult Scler. 2020 Sep;26(10):1157-1162. doi: 10.1177/1352458520941485. Epub 2020 Jul 14.

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score
Amy Kunchok, Jeannette Lechner-Scott, Franco Granella, Maria Trojano, Raed Alroughani, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Marco Onofrj, Serkan Ozakbas, Guillermo Izquierdo, Pierre Grammond, Jose Luis Sanchez-Menoyo, Bart Van Wijmeersch, Cavit Boz, Eugenio Pucci, Pamela McCombe, Francois Grand'Maison, Daniele Spitaleri, Steve Vucic, Raymond Hupperts, Vilija Jokubaitis, Maria Pia Sormani, Helmut Butzkueven, Tomas Kalincik, MSBase Study Group
Mult Scler. 2021 Apr;27(5):695-705. doi: 10.1177/1352458520936823. Epub 2020 Jul 8.

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis
Minh Le, Charles Malpas, Sifat Sharmin, Dana Horáková, Eva Havrdova, Maria Trojano, Guillermo Izquierdo, Sara Eichau, Serkan Ozakbas, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Catherine Larochelle, Raed Alroughani, Roberto Bergamaschi, Patrizia Sola, Diana Ferraro, Pierre Grammond, Francois Grand' Maison, Murat Terzi, Cavit Boz, Raymond Hupperts, Helmut Butzkueven, Eugenio Pucci, Franco Granella, Vincent Van Pesch, Aysun Soysal, Bassem I Yamout, Jeannette Lechner-Scott, Daniele LA Spitaleri, Radek Ampapa, Recai Turkoglu, Gerardo Iuliano, Cristina Ramo-Tello, Jose Luis Sanchez-Menoyo, Youssef Sidhom, Riadh Gouider, Vahid Shaygannejad, Julie Prevost, Ayse Altintas, Yara Dadalti Fragoso, Pamela Ann McCombe, Thor Petersen, Mark Slee, Michael H Barnett, Steve Vucic, Anneke Van Der Walt, Tomas Kalincik
Mult Scler. 2021 Apr;27(5):755-766. doi: 10.1177/1352458520926955. Epub 2020 Jun 15.

Aggressive multiple sclerosis (1): Towards a definition of the phenotype
Ellen Iacobaeus, Georgina Arrambide, Maria Pia Amato, Tobias Derfuss, Sandra Vukusic, Bernhard Hemmer, Mar Tintore, Lou Brundin, 2018 ECTRIMS Focused Workshop Group
Mult Scler. 2020 Jun 12;26(9):1352458520925369. doi: 10.1177/1352458520925369. Online ahead of print.

Aggressive multiple sclerosis (2): Treatment
Georgina Arrambide, Ellen Iacobaeus, Maria Pia Amato, Tobias Derfuss, Sandra Vukusic, Bernhard Hemmer, Lou Brundin, Mar Tintore, 2018 ECTRIMS Focused Workshop Group
Mult Scler. 2020 Jun 12;26(9):1352458520924595. doi: 10.1177/1352458520924595. Online ahead of print.

Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy
Nathaniel Lizak, Suzanne Hodgkinson, Ernest Butler, Jeannette Lechner-Scott, Mark Slee, Pamela Ann McCombe, Cameron Shaw, Olga Skibina, Steve Vucic, Neil Shuey, Michael H Barnett, John Parratt, Helmut Butzkueven, Dominic Jack, Jessica Fabris, Tomas Kalincik
Mult Scler. 2021 Mar;27(3):465-474. doi: 10.1177/1352458520921087. Epub 2020 Jun 12.

The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis
Charmaine Yam, Daniel Merlo, Jim Stankovich, David Darby, Melissa Gresle, Tomas Kalincik, Trevor J Kilpatrick, Jeanette Lechner-Scott, Bruce Taylor, Michael Barnett, Helmut Butzkueven, Anneke van der Walt
Mult Scler Relat Disord. 2020 Aug;43:102212. doi: 10.1016/j.msard.2020.102212. Epub 2020 May 25.

Early clinical markers of aggressive multiple sclerosis
Charles B Malpas, Ali Manouchehrinia, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Guillermo Izquierdo, Sara Eichau, Roberto Bergamaschi, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Francois Grand'Maison, Serkan Ozakbas, Vincent Van Pesch, Franco Granella, Raymond Hupperts, Eugenio Pucci, Cavit Boz, Youssef Sidhom, Riadh Gouider, Daniele Spitaleri, Aysun Soysal, Thor Petersen, Freek Verheul, Rana Karabudak, Recai Turkoglu, Cristina Ramo-Tello, Murat Terzi, Edgardo Cristiano, Mark Slee, Pamela McCombe, Richard Macdonell, Yara Fragoso, Javier Olascoaga, Ayse Altintas, Tomas Olsson, Helmut Butzkueven, Jan Hillert, Tomas Kalincik
Brain. 2020 May 1;143(5):1400-1413. doi: 10.1093/brain/awaa081.

The histopathological staging of tau, but not amyloid, corresponds to antemortem cognitive status, dementia stage, functional abilities and neuropsychiatric symptoms
Charles B Malpas, Sifat Sharmin, Tomas Kalincik
Int J Neurosci. 2021 Aug;131(8):800-809. doi: 10.1080/00207454.2020.1758087. Epub 2020 Apr 30.

Monitoring of radiologic disease activity by serum neurofilaments in MS
Tomas Uher, Sabine Schaedelin, Barbora Srpova, Christian Barro, Niels Bergsland, Michael Dwyer, Michaela Tyblova, Karolina Vodehnalova, Pascal Benkert, Johanna Oechtering, David Leppert, Yvonne Naegelin, Jan Krasensky, Manuela Vaneckova, Eva Kubala Havrdova, Ludwig Kappos, Robert Zivadinov, Dana Horakova, Jens Kuhle, Tomas Kalincik
Neurol Neuroimmunol Neuroinflamm. 2020 Apr 9;7(4):e714. doi: 10.1212/NXI.0000000000000714. Print 2020 Jul.

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Anna He, Bernd Merkel, James William L Brown, Lana Zhovits Ryerson, Ilya Kister, Charles B Malpas, Sifat Sharmin, Dana Horakova, Eva Kubala Havrdova, Tim Spelman, Guillermo Izquierdo, Sara Eichau, Maria Trojano, Alessandra Lugaresi, Raymond Hupperts, Patrizia Sola, Diana Ferraro, Jan Lycke, Francois Grand'Maison, Alexandre Prat, Marc Girard, Pierre Duquette, Catherine Larochelle, Anders Svenningsson, Thor Petersen, Pierre Grammond, Franco Granella, Vincent Van Pesch, Roberto Bergamaschi, Christopher McGuigan, Alasdair Coles, Jan Hillert, Fredrik Piehl, Helmut Butzkueven, Tomas Kalincik, MSBase study group
Lancet Neurol. 2020 Apr;19(4):307-316. doi: 10.1016/S1474-4422(20)30067-3. Epub 2020 Mar 18.

Correction to: Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial
Litza Kiropoulos, Trevor Kilpatrick, Tomas Kalincik, Leonid Churilov, Elizabeth McDonald, Tissa Wijeratne, Jennifer Threader, Vanja Rozenblat, Neil O'Brien-Simpson, Anneke Van Der Walt, Lisa Taylor
Trials. 2020 Mar 20;21(1):284. doi: 10.1186/s13063-020-04261-x.

Presentation and outcome of patients with intracranial tuberculoma in a high HIV prevalence setting
S Marais, I Roos, A Mitha, V Patel, T Kalincik, A I Bhigjee
Int J Tuberc Lung Dis. 2020 Feb 1;24(2):224-232. doi: 10.5588/ijtld.19.0386.

Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial
Litza Kiropoulos, Trevor Kilpatrick, Tomas Kalincik, Leonid Churilov, Elizabeth McDonald, Tissa Wijeratne, Jennifer Threader, Vanja Rozenblat, Neil O’Brien-Simpson, Anneke Van Der Walt, Lisa Taylor
Trials. 2020 Jan 20;21(1):100. doi: 10.1186/s13063-019-4018-8.

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder
Amy Kunchok, Charles Malpas, Petra Nytrova, Eva Kubala Havrdova, Raed Alroughani, Murat Terzi, Bassem Yamout, Jyh Yung Hor, Rana Karabudak, Cavit Boz, Serkan Ozakbas, Javier Olascoaga, Magdolna Simo, Franco Granella, Francesco Patti, Pamela McCombe, Tunde Csepany, Bhim Singhal, Roberto Bergamaschi, Yara Fragoso, Talal Al-Harbi, Recai Turkoglu, Jeannette Lechner-Scott, Guy Laureys, Celia Oreja-Guevara, Eugenio Pucci, Patrizia Sola, Diana Ferraro, Ayse Altintas, Aysun Soysal, Steve Vucic, Francois Grand'Maison, Guillermo Izquierdo, Sara Eichau, Alessandra Lugaresi, Marco Onofrj, Maria Trojano, Mark Marriott, Helmut Butzkueven, Ilya Kister, Tomas Kalincik
Mult Scler Relat Disord. 2020 Feb;38:101868. doi: 10.1016/j.msard.2019.101868. Epub 2019 Nov 25.

Psychometric properties of the Hospital Anxiety and Depression Scale in an inpatient video-monitoring epilepsy cohort
Lara McCartney, Benjamin Johnstone, Terence O'Brien, Patrick Kwan, Tomas Kalincik, Dennis Velakoulis, Charles Malpas
Epilepsy Behav. 2020 Feb;103(Pt A):106631. doi: 10.1016/j.yebeh.2019.106631. Epub 2019 Dec 20.

Distinct psychopathology profiles in patients with epileptic seizures compared to non-epileptic psychogenic seizures
Albert D Wang, Michelle Leong, Benjamin Johnstone, Genevieve Rayner, Tomas Kalincik, Izanne Roos, Patrick Kwan, Terence J O'Brien, Dennis Velakoulis, Charles B Malpas
Epilepsy Res. 2019 Dec;158:106234. doi: 10.1016/j.eplepsyres.2019.106234. Epub 2019 Nov 1.

Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype
Yuan Zhou, Suzi B Claflin, Jim Stankovich, Ingrid van der Mei, Steve Simpson, Richard H Roxburgh, Tomas Kalincik, Leigh Blizzard, Alessandra Lugaresi, Raed Alroughani, Seyed Aidin Sajedi, Helmut Butzkueven, Eugenio Pucci, Daniele LA Spitaleri, Franco Granella, Edgardo Cristiano, Bassem Yamout, Stella Hughes, Riadh Gouider, José Luis Sánchez Menoyo, Javier Olascoaga, Chris McGuigan, Cameron Shaw, Allan G Kermode, Krisztian Kasa, Talal Al-Harbi, Ayse Altintas, Guy Laureys, Yara Fragoso, Todd A Hardy, Tunde Csepany, Carmen-Adella Sirbu, Danny Decoo, Attila Sas, Jose C Alvarez-Cermeño, Karim Kotkata, Jorge Millán-Pascual, Bruce V Taylor
Mult Scler. 2020 Nov;26(13):1765-1774. doi: 10.1177/1352458519881994. Epub 2019 Oct 31.

Abbreviated assessment of psychopathology in patients with suspected seizure disorders
Charles B Malpas, Albert D Wang, Michelle Leong, Benjamin Johnstone, Genevieve Rayner, Tomas Kalincik, Patrick Kwan, Terence J O'Brien, Dennis Velakoulis
Epilepsy Behav. 2019 Nov;100(Pt A):106530. doi: 10.1016/j.yebeh.2019.106530. Epub 2019 Oct 25.

Personality profiles differ between patients with epileptic seizures and patients with psychogenic non-epileptic seizures
Michelle Leong, Albert D Wang, David Trainor, Ben Johnstone, Genevieve Rayner, Tomas Kalincik, Izanne Roos, Patrick Kwan, Terence J O'Brien, Dennis Velakoulis, Charles B Malpas
Seizure. 2019 Dec;73:1-8. doi: 10.1016/j.seizure.2019.10.011. Epub 2019 Oct 17.

Head-to-head drug comparisons in multiple sclerosis: Urgent action needed
Carmen Tur, Tomas Kalincik, Jiwon Oh, Maria P Sormani, Mar Tintoré, Helmut Butzkueven, Xavier Montalban
Neurology. 2019 Oct 29;93(18):793-809. doi: 10.1212/WNL.0000000000008319. Epub 2019 Oct 7.

PACS Integration of Semiautomated Imaging Software Improves Day-to-Day MS Disease Activity Detection
A Dahan, R Pereira, C B Malpas, T Kalincik, F Gaillard
AJNR Am J Neuroradiol. 2019 Oct;40(10):1624-1629. doi: 10.3174/ajnr.A6195. Epub 2019 Sep 12.

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
Fiona Tea, Joseph A Lopez, Sudarshini Ramanathan, Vera Merheb, Fiona X Z Lee, Alicia Zou, Deepti Pilli, Ellis Patrick, Anneke van der Walt, Mastura Monif, Esther M Tantsis, Eppie M Yiu, Steve Vucic, Andrew P D Henderson, Anthony Fok, Clare L Fraser, Jeanette Lechner-Scott, Stephen W Reddel, Simon Broadley, Michael H Barnett, David A Brown, Jan D Lunemann, Russell C Dale, Fabienne Brilot, Australasian and New Zealand MOG Study Group
Acta Neuropathol Commun. 2019 Sep 3;7(1):145. doi: 10.1186/s40478-019-0786-3.

Real-world studies provide reliable comparisons of disease modifying therapies in MS - Yes
Tomas Kalincik
Mult Scler. 2020 Feb;26(2):159-161. doi: 10.1177/1352458519830613. Epub 2019 Sep 3.

Risk of secondary progressive multiple sclerosis: A longitudinal study
Adam Fambiatos, Vilija Jokubaitis, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Alexandre Prat, Marc Girard, Pierre Duquette, Alessandra Lugaresi, Guillermo Izquierdo, Francois Grand'Maison, Pierre Grammond, Patrizia Sola, Diana Ferraro, Raed Alroughani, Murat Terzi, Raymond Hupperts, Cavit Boz, Jeannette Lechner-Scott, Eugenio Pucci, Roberto Bergamaschi, Vincent Van Pesch, Serkan Ozakbas, Franco Granella, Recai Turkoglu, Gerardo Iuliano, Daniele Spitaleri, Pamela McCombe, Claudio Solaro, Mark Slee, Radek Ampapa, Aysun Soysal, Thor Petersen, Jose Luis Sanchez-Menoyo, Freek Verheul, Julie Prevost, Youssef Sidhom, Bart Van Wijmeersch, Steve Vucic, Edgardo Cristiano, Maria Laura Saladino, Norma Deri, Michael Barnett, Javier Olascoaga, Fraser Moore, Olga Skibina, Orla Gray, Yara Fragoso, Bassem Yamout, Cameron Shaw, Bhim Singhal, Neil Shuey, Suzanne Hodgkinson, Ayse Altintas, Talal Al-Harbi, Tunde Csepany, Bruce Taylor, Jordana Hughes, Jae-Kwan Jun, Anneke van der Walt, Tim Spelman, Helmut Butzkueven, Tomas Kalincik
Mult Scler. 2020 Jan;26(1):79-90. doi: 10.1177/1352458519868990. Epub 2019 Aug 9.

Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis
Daniel Ontaneda, Emma Tallantyre, Tomas Kalincik, Sarah M Planchon, Nikos Evangelou
Lancet Neurol. 2019 Oct;18(10):973-980. doi: 10.1016/S1474-4422(19)30151-6. Epub 2019 Jul 30.

The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis
Daniel Merlo, David Darby, Tomas Kalincik, Helmut Butzkueven, Anneke van der Walt
Ther Adv Neurol Disord. 2019 Jul 12;12:1756286419859183. doi: 10.1177/1756286419859183. eCollection 2019.

The MSBase registry: Informing clinical practice
Tomas Kalincik, Helmut Butzkueven
Mult Scler. 2019 Dec;25(14):1828-1834. doi: 10.1177/1352458519848965. Epub 2019 May 23.

Effectiveness of oral multiple sclerosis therapies in clinical context
Tomas Kalincik
Neurology. 2019 Apr 16;92(16):737-738. doi: 10.1212/WNL.0000000000007300. Epub 2019 Mar 15.

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
J William L Brown, Alasdair Coles, Dana Horakova, Eva Havrdova, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Maria Trojano, Alessandra Lugaresi, Roberto Bergamaschi, Pierre Grammond, Raed Alroughani, Raymond Hupperts, Pamela McCombe, Vincent Van Pesch, Patrizia Sola, Diana Ferraro, Francois Grand'Maison, Murat Terzi, Jeannette Lechner-Scott, Schlomo Flechter, Mark Slee, Vahid Shaygannejad, Eugenio Pucci, Franco Granella, Vilija Jokubaitis, Mark Willis, Claire Rice, Neil Scolding, Alastair Wilkins, Owen R Pearson, Tjalf Ziemssen, Michael Hutchinson, Katharine Harding, Joanne Jones, Christopher McGuigan, Helmut Butzkueven, Tomas Kalincik, Neil Robertson, MSBase Study Group
JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588.

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
Tomas Kalincik, Eva Kubala Havrdova, Dana Horakova, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Marco Onofrj, Alessandra Lugaresi, Serkan Ozakbas, Ludwig Kappos, Jens Kuhle, Murat Terzi, Jeannette Lechner-Scott, Cavit Boz, Francois Grand'Maison, Julie Prevost, Patrizia Sola, Diana Ferraro, Franco Granella, Maria Trojano, Roberto Bergamaschi, Eugenio Pucci, Recai Turkoglu, Pamela A McCombe, Vincent Van Pesch, Bart Van Wijmeersch, Claudio Solaro, Cristina Ramo-Tello, Mark Slee, Raed Alroughani, Bassem Yamout, Vahid Shaygannejad, Daniele Spitaleri, José Luis Sánchez-Menoyo, Radek Ampapa, Suzanne Hodgkinson, Rana Karabudak, Ernest Butler, Steve Vucic, Vilija Jokubaitis, Tim Spelman, Helmut Butzkueven
J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):458-468. doi: 10.1136/jnnp-2018-319831. Epub 2019 Jan 13.

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
Ai-Lan Nguyen, Eva Kubala Havrdova, Dana Horakova, Guillermo Izquierdo, Tomas Kalincik, Anneke van der Walt, Murat Terzi, Raed Alroughani, Pierre Duquette, Marc Girard, Alexandre Prat, Cavit Boz, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Jeannette Lechner-Scott, Michael Barnett, Francois Grand'Maison, Pierre Grammond, Cristina Ramo-Tello, Recai Turkoglu, Pamela McCombe, Eugenio Pucci, Maria Trojano, Franco Granella, Daniele Spitaleri, Vincent Van Pesch, Aysun Soysal, Celia Oreja-Guevara, Freek Verheul, Steve Vucic, Suzanne Hodgkinson, Mark Slee, Radek Ampapa, Julie Prevost, Jose Luis Sanchez Menoyo, Olga Skibina, Claudio Solaro, Javier Olascoaga, Cameron Shaw, Klaus Gregaard Madsen, Kerisha Naidoo, Robert Hyde, Helmut Butzkueven, Vilija Jokubaitis, MSBase Study Group
Mult Scler Relat Disord. 2019 Feb;28:235-243. doi: 10.1016/j.msard.2019.01.003. Epub 2019 Jan 3.

Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy
Thor Ameri Chalmer, Tomas Kalincik, Bjarne Laursen, Per Soelberg Sorensen, Melinda Magyari, Members of Danish Multiple Sclerosis Group
J Neurol. 2019 Feb;266(2):306-315. doi: 10.1007/s00415-018-9126-y. Epub 2018 Dec 4.